A Study Explore WJB001 Capsules in Patients With Advanced Solid Tumors

Clinical trial NCT05773820 · RECRUITING

Trial details

NCT number: NCT05773820
Sponsor: Wigen Biomedicine Technology (Shanghai) Co., Ltd.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumors

Start date: 2023-05-05
Primary completion: 2026-08-08
Enrollment: 210

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.